Showing results (131-140 of 174) with videos related to
Sort By:
Pageof 18
Tumori|February 11, 2012
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic reviewMario Airoldi, Dino Amadori, Sandro Barni, et al.Breast Cancer Research : BCR|March 25, 2021
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trialFrancesca Galardi, Francesca De Luca, Chiara Biagioni, et al.The Lancet. Oncology|September 10, 2018
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trialViviana Galimberti, Bernard F Cole, Giuseppe Viale, et al.Journal of the National Cancer Institute|January 10, 2008
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis, John Crown, Angelo Di Leo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancerMichael F Press, Richard S Finn, David Cameron, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2015
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancerAmir Sonnenblick, Prudence A Francis, Hatem A Azim, et al.Breast Cancer Research : BCR|May 4, 2012
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trialLynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, et al.Breast Cancer Research : BCR|May 31, 2019
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trialLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 TrialYoussef H Zeidan, Joyce G Habib, Lieveke Ameye, et al.Cancers|July 2, 2021
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant SettingSamantha Di Donato, Alessia Vignoli, Chiara Biagioni, et al.Pageof 18